Gerresheimer (GXI) Given a €65.00 Price Target at Kepler Capital Markets

Kepler Capital Markets set a €65.00 ($80.25) price objective on Gerresheimer (ETR:GXI) in a research note published on Friday morning. The brokerage currently has a sell rating on the stock.

GXI has been the subject of a number of other research reports. JPMorgan Chase & Co. set a €87.70 ($108.27) price objective on shares of Gerresheimer and gave the company a buy rating in a research report on Thursday, January 4th. Credit Suisse Group set a €75.00 ($92.59) price objective on shares of Gerresheimer and gave the company a buy rating in a research report on Wednesday, February 21st. DZ Bank reissued a buy rating on shares of Gerresheimer in a research report on Monday, February 26th. Deutsche Bank set a €64.00 ($79.01) price objective on shares of Gerresheimer and gave the company a neutral rating in a research report on Friday, December 1st. Finally, Hauck & Aufhaeuser set a €55.00 ($67.90) target price on shares of Gerresheimer and gave the company a sell rating in a report on Wednesday, January 24th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the company. The company presently has an average rating of Hold and an average target price of €69.85 ($86.24).

How to Become a New Pot Stock Millionaire

Gerresheimer stock opened at €66.70 ($82.35) on Friday. The firm has a market cap of $2,100.00 and a P/E ratio of 20.78. Gerresheimer has a 52-week low of €59.97 ($74.04) and a 52-week high of €78.25 ($96.60).

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3276420/gerresheimer-gxi-given-a-65-00-price-target-at-kepler-capital-markets.html.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Smart Sand  Expected to Post Earnings of $0.08 Per Share
Smart Sand Expected to Post Earnings of $0.08 Per Share
JetPay  Getting Favorable News Coverage, Accern Reports
JetPay Getting Favorable News Coverage, Accern Reports
Glen Burnie Bancorp  Receives News Sentiment Rating of -0.08
Glen Burnie Bancorp Receives News Sentiment Rating of -0.08
MKS Instruments  Releases Q2 Earnings Guidance
MKS Instruments Releases Q2 Earnings Guidance
Vipshop  versus Qurate Retail Group  Critical Contrast
Vipshop versus Qurate Retail Group Critical Contrast
Reviewing Chunghwa Telecom  and Cellcom
Reviewing Chunghwa Telecom and Cellcom


© 2006-2018 Ticker Report. Google+.